Infectious diseases specialist Dr Ripley Ballou is working on GSK’s Ebola vaccine
Prior to last year, infectious diseases specialist Dr Ripley Ballou knew very little about Ebola. “I was a novice – I’d never seen an Ebola patient or touched an Ebola vaccine before last summer,” he says.
He is better known for helping to discover the world’s first vaccine against malaria. Now head of clinical research and translational science in the vaccines division at GSK, he has devoted some 30 years to discovering the vaccine, which is going through regulatory approval and should be launched next year.